1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow NK-Cell Leukemia: new trials by email Literature Review of NK-Cell Leukemia trials Research Report on NK-Cell Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma Methotrexate, pralatraxate,, Ifosfamide - NK-Cell Lymphoma, NK-Cell Leukemia | Early Phase 1 | Recruiting | New York Medical College | 40 | 2019-03-01 | 2026-08-18 |
Leukemia, Large Granular Lymphocytic (1) · Lymphoma, T-Cell, Peripheral (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, T-Cell (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Brentuximab Vedotin (1) · Cyclophosphamide (1) · Dexamethasone (1) · Doxorubicin (1) · Etoposide (1) · Ifosfamide (1) · Methotrexate (1) · Prednisone (1) · calaspargase pegol (1)
United States (1)